How it feels with the tables turned
This article was originally published in The Gold Sheet
Executive Summary
An FDA working group is meeting weekly to prepare for a second-round audit by the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S), an international organization of pharmaceutical inspection agencies that is considering FDA's membership application, FDA's Brian Hasselbalch told the FDA/Xavier University Global Outsourcing Conference last month in Cincinnati. As with congressional oversight, "Having the tables turned on you is not pleasant," he said, but "I think we're a better agency for it." One issue is FDA's continuing inability to mandate recalls, something Congress is working to address
You may also be interested in...
Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: